Cas no 90140-21-9 (N-(2-aminophenyl)-N-methyl-methanesulfonamide)
N-(2-aminophenyl)-N-methyl-methanesulfonamide Chemical and Physical Properties
Names and Identifiers
-
- Methanesulfonamide, N-(2-aminophenyl)-N-methyl-
- N-(2-aminophenyl)-N-methylmethanesulfonamide
- Methanesulfonanilide, 2′-amino-N-methyl- (7CI)
- N-(2-Aminophenyl)-N-methylmethanesulfonamide (ACI)
- N-(2-aminophenyl)-N-methyl-methanesulfonamide
- N-(2-Amino-phenyl)-N-methyl-methanesulfonamide
- 90140-21-9
- MFCD16158909
- YPMKIXADVWKELK-UHFFFAOYSA-N
- SCHEMBL1291268
- SB77980
- SY142442
- CS-0160056
- D83487
- Z905156774
- AKOS011270975
- DTXSID90536489
- N-(2-Aminophenyl)-N-methyl methanesulfonamide
- BS-17817
- EN300-106291
- DB-143624
-
- MDL: MFCD16158909
- Inchi: 1S/C8H12N2O2S/c1-10(13(2,11)12)8-6-4-3-5-7(8)9/h3-6H,9H2,1-2H3
- InChI Key: YPMKIXADVWKELK-UHFFFAOYSA-N
- SMILES: O=S(C)(N(C)C1C(N)=CC=CC=1)=O
Computed Properties
- Exact Mass: 200.06194880g/mol
- Monoisotopic Mass: 200.06194880g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 13
- Rotatable Bond Count: 2
- Complexity: 258
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.4
- Topological Polar Surface Area: 71.8?2
N-(2-aminophenyl)-N-methyl-methanesulfonamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-LR025-100mg |
N-(2-aminophenyl)-N-methyl-methanesulfonamide |
90140-21-9 | 97% | 100mg |
701CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-LR025-250mg |
N-(2-aminophenyl)-N-methyl-methanesulfonamide |
90140-21-9 | 97% | 250mg |
1569CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-LR025-1g |
N-(2-aminophenyl)-N-methyl-methanesulfonamide |
90140-21-9 | 97% | 1g |
2872.0CNY | 2021-07-17 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X24295-1g |
N-(2-Aminophenyl)-N-methylmethanesulfonamide |
90140-21-9 | 97% | 1g |
¥806.0 | 2024-07-18 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X24295-5g |
N-(2-Aminophenyl)-N-methylmethanesulfonamide |
90140-21-9 | 97% | 5g |
¥4030.0 | 2024-07-18 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X24295-100mg |
N-(2-Aminophenyl)-N-methylmethanesulfonamide |
90140-21-9 | 97% | 100mg |
¥125.0 | 2024-07-18 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X24295-250mg |
N-(2-Aminophenyl)-N-methylmethanesulfonamide |
90140-21-9 | 97% | 250mg |
¥208.0 | 2024-07-18 | |
| TRC | B406300-25mg |
N-(2-aminophenyl)-N-methylmethanesulfonamide |
90140-21-9 | 25mg |
$ 70.00 | 2022-04-02 | ||
| TRC | B406300-50mg |
N-(2-aminophenyl)-N-methylmethanesulfonamide |
90140-21-9 | 50mg |
$ 95.00 | 2022-04-02 | ||
| TRC | B406300-250mg |
N-(2-aminophenyl)-N-methylmethanesulfonamide |
90140-21-9 | 250mg |
$ 365.00 | 2022-04-02 |
N-(2-aminophenyl)-N-methyl-methanesulfonamide Related Literature
-
Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
-
Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
-
Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
-
Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
-
Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
Additional information on N-(2-aminophenyl)-N-methyl-methanesulfonamide
Introduction to Methanesulfonamide, N-(2-aminophenyl)-N-methyl- (CAS No. 90140-21-9)
Methanesulfonamide, N-(2-aminophenyl)-N-methyl- (CAS No. 90140-21-9) is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, characterized by its unique molecular structure, plays a crucial role in various biochemical applications. The molecular formula of this compound is C?H??NO?S, and it is classified as an amide derivative of methanesulfonic acid. The presence of both an amino group and a methyl group in its structure contributes to its versatile reactivity and utility in synthetic chemistry.
The CAS No. 90140-21-9 is a unique identifier that distinguishes this compound from others in chemical databases. This numbering system ensures precise identification and classification, which is essential for researchers working in academic, industrial, and clinical settings. The compound's chemical properties make it a valuable intermediate in the synthesis of more complex molecules, particularly in the development of pharmaceutical agents.
In recent years, Methanesulfonamide, N-(2-aminophenyl)-N-methyl- has been extensively studied for its potential applications in drug discovery. Its structural features allow it to interact with biological targets in multiple ways, making it a promising candidate for the development of novel therapeutic agents. Researchers have been exploring its efficacy in various pharmacological contexts, including anti-inflammatory and anticancer therapies.
One of the most intriguing aspects of this compound is its ability to act as a scaffold for drug design. The N-(2-aminophenyl)-N-methyl moiety provides a flexible platform for modifications that can enhance binding affinity and selectivity towards specific biological targets. This has led to several innovative approaches in medicinal chemistry, where small changes in the molecular structure can significantly alter the pharmacological profile of the compound.
Recent studies have highlighted the compound's role in modulating enzyme activity and protein-protein interactions. For instance, researchers have demonstrated that derivatives of Methanesulfonamide, N-(2-aminophenyl)-N-methyl-, can inhibit certain enzymes involved in inflammatory pathways. This finding opens up new avenues for treating chronic inflammatory diseases by targeting key molecular mechanisms.
The synthesis of Methanesulfonamide, N-(2-aminophenyl)-N-methyl-, involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic techniques have been employed to optimize yield and purity, ensuring that the final product meets the stringent requirements of pharmaceutical applications. The use of high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy are common analytical methods used to characterize the compound.
In addition to its pharmaceutical applications, this compound has shown promise in materials science and industrial chemistry. Its unique properties make it suitable for use as a ligand in catalytic systems and as a building block for more complex materials. The ability to functionalize its structure allows researchers to tailor its properties for specific applications, making it a versatile tool in chemical innovation.
The safety profile of Methanesulfonamide, N-(2-aminophenyl)-N-methyl-, is another critical aspect that has been thoroughly evaluated. Extensive toxicological studies have been conducted to assess its potential hazards and safe handling procedures. These studies ensure that researchers and industrial workers can use the compound without compromising their health or safety.
The regulatory landscape governing the use of Methanesulfonamide, N-(2-aminophenyl)-N-methyl-, is designed to ensure responsible innovation while promoting scientific advancement. Compliance with international standards and guidelines ensures that the compound is used ethically and sustainably across various sectors.
Future research directions for Methanesulfonamide, N-(2-aminophenyl)-N-methyl-, include exploring its potential in personalized medicine and combination therapies. The ability to modify its structure allows for the development of customized drug formulations that target specific genetic or molecular profiles of patients. This approach holds great promise for improving treatment outcomes and reducing side effects associated with conventional therapies.
The interdisciplinary nature of research involving Methanesulfonamide, N-(2-aminophenyl)-N-methyl-, underscores its importance as a tool for scientific discovery. Collaboration between chemists, biologists, pharmacologists, and clinicians is essential for maximizing its potential benefits. By leveraging cutting-edge technologies and innovative methodologies, researchers can unlock new therapeutic possibilities and advance our understanding of complex biological systems.
90140-21-9 (N-(2-aminophenyl)-N-methyl-methanesulfonamide) Related Products
- 143937-54-6(Methanesulfonamide, N-methyl-N-(4-methylphenyl)-)
- 63084-78-6(Methanesulfonamide, N-[4-(dimethylamino)phenyl]-)
- 3989-43-3(Methanesulfonamide,N,N-diphenyl-)
- 68984-89-4(N-(Methanesulfonyl)-N-phenylformamide)
- 3572-85-8(N-(4-Hydroxyphenyl)-N-methylmethanesulfonamide)
- 89777-42-4(1H-1,5-Benzodiazepine, 2,3,4,5-tetrahydro-1,5-bis(methylsulfonyl)-)
- 7596-80-7(1,2-Bis(methanesulfonamido)benzene)
- 37073-18-0(2-(Methylsulfonamido)aniline)
- 251552-20-2(N-(4-Aminophenyl)-N-methylmethanesulfonamide)
- 13229-35-1(N-methyl-N-phenylmethanesulfonamide)